| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b22aeb16cbdc8b0358ec9bd0106d3fc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40abddf9e66b40d35998480325cf1a3f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate |
2022-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af63bbf7baccfdc3689556d7c25deee5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_704bd6d13b537cc72ff12eab85a3393d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f17ecc75a6ca08180f6f205a396ecc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6884b881b289da617e6b4cf4554b8ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f5b743ff3c9bfc398799b0b726e8b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7024536bb61bfe7a6c0ae999c9f8ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6af5eac6715cf12c31fff2e0a24603 |
| publicationDate |
2022-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022362183-A1 |
| titleOfInvention |
Use of belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection |
| abstract |
Disclosed is the use of Belinostat or a pharmaceutically acceptable salt thereof in preparation of a drug for treating an infection. Also disclosed are related methods and compositions. |
| priorityDate |
2021-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |